Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China
· Delayed Price · Currency is CNY 20.93
-0.16 (-0.76%)
Apr 30, 2026, 1:55 PM CST
SHA:605177 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 2,374 | 2,003 | 2,218 | 3,008 | 2,274 | 3,140 | Upgrade
|
| Market Cap Growth | 6.54% | -9.67% | -26.27% | 32.27% | -27.57% | -22.14% | Upgrade
|
| Enterprise Value | 3,004 | 2,617 | 2,681 | 2,732 | 1,902 | 2,504 | Upgrade
|
| Last Close Price | 21.09 | 17.80 | 19.70 | 26.08 | 19.48 | 26.64 | Upgrade
|
| PE Ratio | - | - | - | 24.81 | 21.78 | 45.84 | Upgrade
|
| Forward PE | - | 8.48 | 10.15 | 18.20 | - | - | Upgrade
|
| PS Ratio | 2.52 | 2.13 | 1.85 | 2.22 | 1.93 | 4.41 | Upgrade
|
| PB Ratio | 1.31 | 1.11 | 1.18 | 1.49 | 1.24 | 1.79 | Upgrade
|
| P/TBV Ratio | 1.36 | 1.15 | 1.22 | 1.54 | 1.28 | 1.83 | Upgrade
|
| EV/Sales Ratio | 3.20 | 2.78 | 2.24 | 2.01 | 1.61 | 3.52 | Upgrade
|
| EV/EBITDA Ratio | 24.49 | 21.62 | 123.59 | 12.41 | 10.53 | 24.56 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 24.43 | 21.49 | 76.37 | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.55 | 0.42 | 0.35 | 0.07 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 8.11 | 8.11 | 30.46 | 3.15 | 0.67 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | 0.35 | 0.35 | 0.12 | -0.09 | -0.22 | -0.34 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.21 | 5.21 | 10.60 | -0.83 | -2.26 | -5.92 | Upgrade
|
| Net Debt / FCF Ratio | -1.84 | -1.84 | -0.62 | 0.59 | 2.59 | 4.15 | Upgrade
|
| Asset Turnover | 0.27 | 0.27 | 0.35 | 0.47 | 0.50 | 0.33 | Upgrade
|
| Inventory Turnover | 1.14 | 1.14 | 1.50 | 1.83 | 2.03 | 1.52 | Upgrade
|
| Quick Ratio | 0.80 | 0.80 | 0.82 | 1.58 | 1.22 | 1.64 | Upgrade
|
| Current Ratio | 1.73 | 1.73 | 1.67 | 2.50 | 2.09 | 2.61 | Upgrade
|
| Return on Equity (ROE) | -4.48% | -4.48% | -5.18% | 6.29% | 5.80% | 3.93% | Upgrade
|
| Return on Assets (ROA) | -0.55% | -0.55% | -1.99% | 2.40% | 2.34% | 0.95% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.26% | -1.34% | -5.58% | 6.17% | 6.21% | 3.06% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.20% | -1.20% | -4.20% | 4.20% | 4.70% | 1.80% | Upgrade
|
| Earnings Yield | -3.47% | -4.11% | -4.54% | 4.03% | 4.59% | 2.18% | Upgrade
|
| FCF Yield | -14.45% | -17.13% | -16.60% | -10.36% | -6.96% | -4.64% | Upgrade
|
| Dividend Yield | - | - | - | 1.25% | 1.49% | 0.75% | Upgrade
|
| Payout Ratio | - | - | - | 29.90% | 22.37% | 57.00% | Upgrade
|
| Buyback Yield / Dilution | -17.66% | -53.47% | 10.52% | -10.13% | 0.57% | -30.62% | Upgrade
|
| Total Shareholder Return | -17.66% | -53.47% | 10.52% | -8.87% | 2.06% | -29.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.